This document discusses new data and ongoing controversy regarding the use of hormonal contraception by women with or at risk of HIV. It summarizes findings from systematic reviews that examined whether certain contraceptive methods increase the risk of HIV acquisition, transmission, or disease progression. For HIV-negative women, data do not suggest oral contraceptives increase HIV risk, while evidence for injectables is more limited. For HIV-positive women, studies generally found hormonal contraception does not accelerate disease progression. Evidence on transmission risk is limited and inconsistent. The document concludes that further research is still needed to clarify HIV risks related to certain contraceptive methods.